Abstract Background Junior doctors commonly prescribe inhaled medication for patients admitted to hospitals, and this may be a potential source of prescription error. Objective To determine the potential type, frequency and cost of prescription errors for inhaled medication, and ascertain if a simple educational intervention can improve junior doctors' knowledge and reduce these. Methods We carried out a prospective study looking at the types and cost of inhaled prescription errors. Simultaneously we tested knowledge of junior doctors' using a quiz. Both the studies were carried out before and after the introduction of inhaler flash cards (pictures of devices with, instructions on use and the medication they contain) on specific wards. This was followed by an electronic feedback survey. Results Error rates varied greatly (p = 6.8 9 10 -8 ) by device, with 23 % of Evohaler and Accuhaler prescriptions being incorrect. The average cost of an erroneously prescribed medication was £45.50. There were 14 % incorrect prescriptions before the intervention. There was no significant improvement in junior doctors' knowledge of inhalers or the rate of prescription error after the intervention. Conclusion Prescription errors of inhaled medication are common and costly to rectify. There is a need for improved teaching and training of junior doctors and medical students.
Impacts on practice
• Inhaled medication is prescribed frequently. Errors in these prescriptions are a source of clinical risk and costly as the device once dispensed has to be discarded, with multiple doses being wasted.
• A simple educational intervention appears insufficient to address this problem, but a broader educational programme for junior doctors could potentially improve their knowledge and understanding of inhaled medication.
Background
Medical error is a source of significant morbidity and mortality, and is often related to the prescription of medication(s) [1] . Prescription errors are related to inadequate knowledge or mistakes when dealing with relatively unfamiliar information whilst under pressure [2, 3] . Lack of relevant knowledge is a special concern amongst newly qualified doctors [4, 5] . These errors can lead to serious adverse outcomes for patients, and are a source of inefficiency in healthcare systems [6] . Asthma and chronic obstructive airways disease (COPD) are common respiratory conditions which require long-term therapy in the form of inhaled medication. The global burden of these conditions is significant and increasing, with the WHO estimating they affect over 500 million people [7] . Providing inhaled medication for airways disease is a major financial burden for healthcare systems.
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It is common for individuals on inhaled treatment to be admitted to hospital, and on admission junior doctors prescribe these usual medications [8, 9] . Medications which are available in different preparations, for example modified or slow release are more likely to generate prescription errors [10] . These factors are important for inhaled medication, as many are available in a number of varying strengths and combinations in different devices. Any errors made in the prescription of inhalers are potentially more costly than for oral formulations as each erroneously prescribed device usually represents one month's supply and cannot be reused once opened.
Despite the frequency of prescription, the high risk of errors, and the significant resultant cost, we are not aware of any studies that have specifically investigated the frequency of errors in prescription of inhaled medications.
Aim of the study
Our aim was to quantify the type, frequency and cost of prescription errors for inhaled medication in clinical practice, and to determine if a simple educational intervention can improve the knowledge of junior doctors for these medications.
Ethical approval
This study met criteria for service evaluation and in the United Kingdom ethical approval is not required for this.
Methods
This prospective study was conducted at a university teaching hospital in the United Kingdom with approximately 700 beds. Data were collected in two ways.
Inhaler prescription errors
We collected data on prescription of inhalers for all admissions from an electronic prescribing system (JAC, Basildon, UK). The initial data collection period was each weekend (from 5 p.m. Friday to 8 a.m. Monday) from 17th May to 15th July 2013. We recorded instances where an initial prescription was corrected by a pharmacist, who had obtained a full medication history. The incorrect prescription was classified as being for the wrong device, strength, or drug, or a combination of these problems. Examples of these errors are shown in Table 1 .
The cost of the incorrectly prescribed inhaler was drawn from the hospital's internal formulary costing.
Knowledge assessment
We ascertained the knowledge of inhaled therapy amongst junior staff through a quiz directly delivered at teaching sessions for Foundation level (years 1 and 2) doctors. This quiz comprised of a slideshow with short questions developed by the authors and delivered by a respiratory clinician. The questions were simple such as identifying a common device (e.g. Accuhaler Ò ), showing a picture of a device and asking to name a possible medication that could be delivered with it (e.g. Turbohaler Ò ).
Educational intervention
In August 2013 with the new intake of junior doctors, we introduced inhaler flashcards onto medical wards and admission areas, and publicised their availability and locations. Awareness was raised through teaching sessions for junior doctors and lunchtime speciality meetings, where these were shown. The packs of laminated cards had pictures of inhaler devices on one side with instructions on Both the inhaler prescription data collection and knowledge assessment were repeated 4 weeks after the introduction of inhaler flash cards. The prescription data were collected during the weekends between the 30th August and 20th October 2013, and the knowledge assessment quiz was repeated at teaching sessions in October 2013.
After completion of our study, we circulated an electronic questionnaire to staff members, including senior doctors and nurses of the hospital for feedback on the flash cards.
Analyses and statistics
The percentage error was calculated by dividing the number of prescriptions containing errors by the total number of prescriptions. The cost of per error was calculated by dividing the total cost of incorrect prescriptions by the total number of incorrect prescriptions. This was done separately for the two data collection periods, and overall.
The frequency of errors pre-and post-intervention was compared using the Chi square test. The frequency of error by inhaler device type used a combined set of pre-and post-intervention data. The Mann-Whitney Test was applied to the doctors' quiz responses, and the t test was used to calculate the cost of prescription errors.
Results

Prescription errors
A total of 504 inhalers were prescribed during the weekends studied and for 489 prescriptions (97 %) an independent drug history was subsequently available. Prescription error was common throughout the study (14 % of cases overall), with types of errors shown in Fig. 1 .
Inhaler type was significantly associated with error rate by Chi square (p = 6.8 9 10 -8 ): Higher error rates were seen with prescriptions for Evohaler Ò and Accuhaler Ò (53 of 195 prescriptions for which full data was available contained an error, all involved Seretide Ò ) than other devices (errors in 20 of 219 prescriptions for which full data was available).
The educational intervention was not associated with a significantly reduced error rate [14 % (n = 34/243) vs. 13 % (n = 27/207), Chi square p = 0.79]. The mean cost of prescribing errors was £47 per error before the intervention and £44 per error afterward (t test p = 0.36, 95 % CI for difference -3.6 to 10).
Knowledge assessment
Overall 30 doctors participated in the questionnaire before the introduction of inhaler cards, and 21 after. Median scores were 4/26 before the intervention and 5/26 afterwards (Mann-Whitney test p = 0.17). 
Online electronic questionnaire
This drew 64 responses, with 66 % of respondents being aware of the cards and 54 % having either read or used them. Of these 76 % found these either useful or extremely useful and suggested the need for staff training and teaching.
Discussion
This study shows, for the first time, that errors in the prescription of common inhaled medication are frequent and of a compound nature. They are also costly, being the equivalent of adding an extra £7 to the cost of every inhaler prescribed. Error rates were highest for medications such as Seretide Ò (Fluticasone/Salmeterol) that can be prescribed in multiple doses and devices.
We studied weekends as junior doctors have greater time pressure, more distractions, and less supervision, and pharmacy provision is lower. This means that prescription errors may be more likely to occur, and translated into wrong drug being delivered and potentially administered. However, a study during the working week and on weekends simultaneously would have enabled us to confirm or refute this assumption.
The intervention of inhaler flash cards was chosen for its potential ease of implementation and the simple, clear design. These were concise with only necessary and relevant information to enable medical professionals to refer to them during their busy schedule. This intervention of disseminating inhaler flashcards was not associated with a change in junior doctors' knowledge, nor in prescribing error frequency in our small, single centre study.
We acknowledge the limitations of reporting ''before and after'' data recorded alongside a clinical intervention rather than a stand-alone research project. A key issue was the rotation of junior doctors, meaning overlapping but not identical sets of doctors undertook the two sets of assessments, and not all of those who completed the second assessment were aware of the flashcards. Our findings are therefore representative of a ''real world'' effect rather than a clear measure of the efficacy of the intervention.
This study highlights a gap in the knowledge of junior doctors, and current educational curriculum of medical students. The feedback received from the electronic questionnaire was positive, with all the respondents suggesting to continue using these cards on the wards and requesting more education and training in this area. The need for further studies has been highlighted in earlier studies looking at medication errors [4, 5] . Harding et al. tested junior doctors' knowledge formally, in a more comprehensive manner using extended matching choice questions (EMQs) and written unobserved structured clinical examination scenarios (WUSCE). They found a large proportion (range 51-75 and 27-70 % for EMQs and WUSCE) junior doctors failed in these [4] . There is a need for emphasis on this subject at undergraduate level and for further teaching and training of the newly qualified medical professionals. We hope the findings in this report will inform the design of future prospective multicentre trials of educational interventions.
Conclusion
Errors in the prescription of inhaled medications in hospital are very common and costly for healthcare providers. A simple educational intervention of teaching sessions and flashcards did not reduce error rates.
Given the potential financial savings if errors are avoided, more complex interventions may well prove cost effective.
